{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:16:05Z","timestamp":1785813365544,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017882","name":"Wuhan Yellow Crane Talents Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB907"],"award-info":[{"award-number":["2023AFB907"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jad.2025.120355","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:11:11Z","timestamp":1759702271000},"page":"120355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Exploration of the potential association between new oral anticoagulants and anxiety symptoms adverse events: Evidence from a real-world analysis"],"prefix":"10.1016","volume":"393","author":[{"given":"Zhifang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanQiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120355_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-016-0048-5","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese adverse Drug event report database","volume":"2","author":"Abe","year":"2016","journal-title":"J Pharm Health Care Sci."},{"key":"10.1016\/j.jad.2025.120355_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.105.568451","article-title":"Cyclooxygenase inhibition and cardiovascular risk","volume":"112","author":"Antman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2025.120355_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jad.2025.120355_bb0020","series-title":"Chemical Characteristics of Direct FXa Inhibitors Registered for Atrial Fibrillation","author":"Bridoux","year":"2019"},{"key":"10.1016\/j.jad.2025.120355_bb0025","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jth.13139","article-title":"Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Chai-Adisaksopha","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jad.2025.120355_bb0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: Evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.120355_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5582\/bst.2019.01213","article-title":"China has faster pace than Japan in population aging in next 25 years","volume":"13","author":"Chen","year":"2019","journal-title":"Biosci. Trends"},{"issue":"17","key":"10.1016\/j.jad.2025.120355_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179124","article-title":"Gender differences in depressive traits among rural and urban Chinese adolescent students: secondary data analysis of nationwide survey CFPS","volume":"18","author":"Chen","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.jad.2025.120355_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.psyneuen.2007.10.006","article-title":"From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes","volume":"33","author":"Deecher","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl D","key":"10.1016\/j.jad.2025.120355_bb0050","doi-asserted-by":"crossref","first-page":"D293","DOI":"10.1093\/eurheartj\/sux026","article-title":"Anmco position paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention","volume":"19","author":"Enea","year":"2017","journal-title":"Eur. Heart J. Suppl."},{"issue":"3","key":"10.1016\/j.jad.2025.120355_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/psyg.12099","article-title":"Depressive symptoms associated with dabigatran: a case report","volume":"15","author":"Eryilmaz","year":"2015","journal-title":"Psychogeriatrics"},{"issue":"6","key":"10.1016\/j.jad.2025.120355_bb0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2025.120355_bb0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-049750","article-title":"Initiation of opioid prescription and risk of suicidal behavior among youth and young adults","volume":"149","author":"Fine","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2025.120355_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108390","article-title":"How to save a life: from neurobiological underpinnings to psychopharmacotherapies in the prevention of suicide","volume":"244","author":"Gonda","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2025.120355_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070630","article-title":"Suicide in young people: screening, risk assessment, and intervention","volume":"381","author":"Hughes","year":"2023","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jad.2025.120355_bb0080","first-page":"e125","article-title":"2019 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jad.2025.120355_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jad.2025.120355_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/YCO.0000000000000841","article-title":"Update on treatments for anxiety-related disorders","volume":"36","author":"Lee","year":"2023","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120355_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10654-018-0415-7","article-title":"Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"34","author":"Li","year":"2019","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jad.2025.120355_bb0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40264-020-00943-2","article-title":"Combining social media and FDA adverse event reporting system to detect adverse drug reactions","volume":"43","author":"Li","year":"2020","journal-title":"Drug Saf."},{"issue":"11","key":"10.1016\/j.jad.2025.120355_bb0105","doi-asserted-by":"crossref","first-page":"e1563","DOI":"10.4088\/JCP.11com07089","article-title":"Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin","volume":"72","author":"Lokuge","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.120355_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2215-0366(23)00193-1","article-title":"Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries","volume":"10","author":"McGrath","year":"2023","journal-title":"Lancet Psychiat."},{"issue":"1","key":"10.1016\/j.jad.2025.120355_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100015","article-title":"Thrombophilia and outcomes of venous thromboembolism in older patients","volume":"7","author":"M\u00e9an","year":"2022","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.jad.2025.120355_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40780-015-0035-2","article-title":"Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events","volume":"1","author":"Nakamura","year":"2015","journal-title":"J Pharm Health Care Sci."},{"issue":"1","key":"10.1016\/j.jad.2025.120355_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40268-016-0167-3","article-title":"Identification of a syndrome class of neuropsychiatric adverse reactions to mefloquine from latent class modeling of FDA adverse event reporting system data","volume":"17","author":"Nevin","year":"2017","journal-title":"Drugs R D."},{"issue":"1","key":"10.1016\/j.jad.2025.120355_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat. Methods Med. Res."},{"issue":"3","key":"10.1016\/j.jad.2025.120355_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240059","article-title":"Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)","volume":"14","author":"Porter","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"19","key":"10.1016\/j.jad.2025.120355_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194610","article-title":"Adrenal insufficiency with anticancer tyrosine kinase inhibitors targeting vascular endothelial growth factor receptor: analysis of the FDA adverse event reporting system","volume":"14","author":"Raschi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jad.2025.120355_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/pds.615","article-title":"The role of databases in drug postmarketing surveillance","volume":"10","author":"Rodriguez","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"12","key":"10.1016\/j.jad.2025.120355_bb0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jad.2025.120355_bb0155","first-page":"9","article-title":"Life event, stress and illness","volume":"15","author":"Salleh","year":"2008","journal-title":"Malays J Med Sci."},{"issue":"10","key":"10.1016\/j.jad.2025.120355_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/a-1001-2154","article-title":"Contrasting role of concentration in rivaroxaban induced toxicity and oxidative stress in isolated kidney mitochondria","volume":"69","author":"Samiei","year":"2019","journal-title":"Drug Res (Stuttg)."},{"key":"10.1016\/j.jad.2025.120355_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115652","article-title":"Mitochondrial dysfunction: a fatal blow in depression","volume":"167","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.jad.2025.120355_bb0170","first-page":"1676","article-title":"European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation [published correction appears in Europace]","volume":"23","author":"Steffel","year":"2021"},{"key":"10.1016\/j.jad.2025.120355_bb0175","first-page":"69","article-title":"The relationship between psychotropic drug use and suicidal behavior in Japan: Japanese adverse drug event report","volume":"50","author":"Takeuchi","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120355_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1359105318776727","article-title":"The prevalence of anxiety on the empty-nest elders in China","volume":"25","author":"Wang","year":"2020","journal-title":"J. Health Psychol."},{"key":"10.1016\/j.jad.2025.120355_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1009226","article-title":"Anxiety symptoms in older Chinese adults in primary care settings: prevalence and correlates","volume":"10","author":"Xie","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jad.2025.120355_bb0190","article-title":"Comparative safety signal assessment of hospitalization associated with the use of atypical antipsychotics","volume":"13","author":"Yunusa","year":"2022","journal-title":"Front. Psych."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725017975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725017975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:02:37Z","timestamp":1780635757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725017975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0165032725017975"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120355","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the potential association between new oral anticoagulants and anxiety symptoms adverse events: Evidence from a real-world analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120355"}}